The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-2-(5-nitrothiophen-2-yl)-1H-benzo[d]imidazole-5-carboxamide
ID: ALA4753223
PubChem CID: 135391734
Max Phase: Preclinical
Molecular Formula: C18H11ClN4O3S
Molecular Weight: 398.83
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1ccc2[nH]c(-c3ccc([N+](=O)[O-])s3)nc2c1
Standard InChI: InChI=1S/C18H11ClN4O3S/c19-11-3-1-2-4-12(11)22-18(24)10-5-6-13-14(9-10)21-17(20-13)15-7-8-16(27-15)23(25)26/h1-9H,(H,20,21)(H,22,24)
Standard InChI Key: BJBGYQJJEIOBGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
34.5642 -14.1979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5631 -15.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2778 -15.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2759 -13.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9912 -14.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9960 -15.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7835 -15.2713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2653 -14.5999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7756 -13.9343 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0913 -14.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5801 -15.2586 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.3631 -14.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3583 -14.1740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5722 -13.9239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0365 -15.4821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7881 -15.1422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.9551 -16.3030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8483 -15.4369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1343 -15.0240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8477 -16.2618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4196 -15.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7064 -15.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9921 -15.4318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9910 -16.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7101 -16.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4213 -16.2569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7083 -14.1958 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
8 10 1 0
15 16 2 0
15 17 1 0
12 15 1 0
2 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
22 27 1 0
M CHG 2 15 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.83 | Molecular Weight (Monoisotopic): 398.0240 | AlogP: 5.11 | #Rotatable Bonds: 4 |
Polar Surface Area: 100.92 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.77 | CX Basic pKa: 3.29 | CX LogP: 4.86 | CX LogD: 4.86 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.37 | Np Likeness Score: -2.15 |
References
1. Sharma, Mousmee, Prasher, Parteek. (2020) An epigrammatic status of the azole-based antimalarial drugs, 11 (2): [PMID:33479627] [10.1039/c9md00479c] |